SO
RYTM icon

STRS Ohio’s Rhythm Pharmaceuticals RYTM Stock Holding History

STRS Ohio’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.51M Buy
28,914
+16,914
+141% +$1.64M 0.01% 550
2025
Q4 		$1.28M Sell
12,000
-2,800
-19% -$297K ﹤0.01% 639
2025
Q3 		$1.49M Sell
14,800
-2,600
-15% -$241K 0.01% 597
2025
Q2 		$1.1M Sell
17,400
-1,100
-6% -$67.4K ﹤0.01% 881
2025
Q1 		$980K Buy
18,500
+2,100
+13% +$117K ﹤0.01% 879
2024
Q4 		$918K Buy
16,400
+10,200
+165% +$563K ﹤0.01% 885
2024
Q3 		$325K Hold
6,200
– – ﹤0.01% 1423
2024
Q2 		$255K Sell
6,200
-7,400
-54% -$295K ﹤0.01% 1493
2024
Q1 		$589K Buy
13,600
+10,600
+353% +$464K ﹤0.01% 1145
2023
Q4 		$137K Buy
+3,000
New +$94.6K ﹤0.01% 1647
2023
Q2 		– Sell
-14,099
Closed -$251K – 2077
2023
Q1 		$251K Buy
+14,099
New +$354K ﹤0.01% 1545
2020
Q1 		– Sell
-2,400
Closed -$55K – 2081
2019
Q4 		$55K Hold
2,400
– – ﹤0.01% 1882
2019
Q3 		$51K Hold
2,400
– – ﹤0.01% 1876
2019
Q2 		$52K Hold
2,400
– – ﹤0.01% 1916
2019
Q1 		$65K Hold
2,400
– – ﹤0.01% 1848
2018
Q4 		$64K Hold
2,400
– – ﹤0.01% 1836
2018
Q3 		$70K Hold
2,400
– – ﹤0.01% 1899
2018
Q2 		$75K Hold
2,400
– – ﹤0.01% 1911
2018
Q1 		$47K Hold
2,400
– – ﹤0.01% 1752
2017
Q4 		$69K Buy
+2,400
New +$63.5K ﹤0.01% 1692

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

STRS Ohio's RYTM Position: Q1 2026 in Review

STRS Ohio increased its Rhythm Pharmaceuticals (RYTM) stake by 141% in Q1 2026, buying an estimated $1.64M and bringing the position to 28,914 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #550.

STRS Ohio first reported a position in RYTM in Q4 2017 and has held it in 20 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • STRS Ohio held 28,914 shares of Rhythm Pharmaceuticals worth $2.51M as of Q1 2026.
  • STRS Ohio bought 16,914 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $1.64M.
  • Rhythm Pharmaceuticals made up 0.01% of STRS Ohio's portfolio in Q1 2026, its #550 holding.
  • STRS Ohio first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 20 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.